For a 47-year-old male weighing 120 kg who is being changed from dexamethasone 10 mg every 6 hours to 10 mg every 12 hours, what should the 10 am Neutral Protamine Hagedorn (NPH) dose be, what should the 8 pm NPH dose be, and what should the insulin sensitivity factor (ISF) and insulin-to-carbohydrate ratio (ICR) be?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Insulin Dosing Adjustment for Dexamethasone Reduction

With the reduction from dexamethasone 10 mg every 6 hours to 10 mg every 12 hours (a 50% reduction in total daily steroid dose), increase the 10 am NPH dose to 35-40 units, maintain the 8 pm NPH dose at 25-30 units, adjust ISF to 1:30, and maintain ICR at 1:6.

Rationale for Dose Adjustments

Your patient's current glucose pattern reveals inadequate control despite significant steroid exposure. The blood glucose trajectory (233→270→317→255 mg/dL) demonstrates persistent afternoon/evening hyperglycemia characteristic of glucocorticoid-induced hyperglycemia, even with the current NPH regimen.

Understanding the Steroid Change Impact

The reduction from 40 mg to 20 mg total daily dexamethasone (10 mg q6h to 10 mg q12h) represents a 50% decrease in glucocorticoid burden. However, dexamethasone has a prolonged duration of action (36-72 hours), and the hyperglycemic effect persists throughout the day with twice-daily dosing 1. The 2022 systematic review specifically notes that "NPH should be administered twice daily instead if dexamethasone is given" due to dexamethasone's extended pharmacokinetic profile 1.

Specific NPH Dose Recommendations

Morning (10 am) NPH Dose: 35-40 units

Increase from 30 to 35-40 units. Your patient demonstrated inadequate afternoon control (BG 270 at 6 pm), indicating insufficient morning NPH coverage. The guideline-based approach for glucocorticoid-induced hyperglycemia recommends 0.1-0.4 units/kg according to steroid dose 1. For this 120 kg patient receiving 10 mg dexamethasone twice daily:

  • At 0.3 units/kg (mid-range for dexamethasone): 36 units
  • This accounts for the persistent hyperglycemic effect of dexamethasone even at reduced dosing

The 2025 ADA Standards recommend increasing doses by 10-15% when inadequate control persists 2. Your current 30 units increased by 15% = 34.5 units, rounded to 35 units minimum.

Evening (8 pm) NPH Dose: 25-30 units

Maintain or slightly increase from 25 to 25-30 units. The overnight glucose pattern (317→255 mg/dL) shows some improvement but remains suboptimal. The evening dexamethasone dose (10 mg at approximately 10 pm based on q12h dosing) will continue driving overnight hyperglycemia.

Critical timing consideration: The 8 pm NPH administration is appropriately timed 2 hours before the evening dexamethasone dose, allowing NPH's peak action (4-8 hours) to coincide with dexamethasone's hyperglycemic effect 1, 3.

Insulin Sensitivity Factor (ISF) Adjustment

New ISF: 1:30 (down from 1:20)

Your patient requires more aggressive correction insulin. The current ISF of 1:20 (meaning 1 unit lowers glucose by 20 mg/dL) is insufficient given persistent hyperglycemia. The 2022 guideline recommends ISF of 1:25 targeting 150 mg/dL for glucocorticoid-induced hyperglycemia 1.

However, your patient's glucose levels consistently exceed 250 mg/dL, indicating greater insulin resistance. Adjust to ISF 1:30 (1 unit lowers glucose by 30 mg/dL), providing more conservative correction that accounts for:

  • Ongoing dexamethasone effect (even at reduced dose)
  • Patient weight (120 kg)
  • Demonstrated insulin resistance pattern

The "1500 rule" calculation: 1500 ÷ estimated TDD (approximately 50-60 units) = ISF of 25-30, supporting this adjustment.

Insulin-to-Carbohydrate Ratio (ICR)

Maintain ICR: 1:6

Keep the current ICR of 1:6 unchanged. This ratio (1 unit per 6 grams carbohydrate) is already aggressive and appropriate for this patient's weight and insulin resistance. The "500 rule" calculation: 500 ÷ estimated TDD (50-60 units) = ICR of 8-10, but glucocorticoid-induced insulin resistance justifies the more aggressive 1:6 ratio 1.

Critical Monitoring and Titration Strategy

Daily Adjustments

Increase NPH doses by 10% daily until fasting and pre-dinner glucose targets <150 mg/dL are achieved 2, 1. The 2025 ADA Standards explicitly recommend "increase 2 units every 3 days to reach FPG goal without hypoglycemia" for standard basal insulin, but glucocorticoid-induced hyperglycemia requires more aggressive titration 2.

Glucose Monitoring Pattern

Check blood glucose:

  • Fasting (assesses overnight NPH)
  • Pre-lunch (assesses morning NPH early effect)
  • Pre-dinner (assesses morning NPH peak effect)
  • Bedtime (assesses evening NPH early effect)
  • 2-3 am if bedtime glucose >250 mg/dL (hypoglycemia risk assessment)

Common Pitfalls to Avoid

  1. Underestimating dexamethasone's persistent effect: Even at 50% dose reduction, dexamethasone maintains significant hyperglycemic impact for 36-72 hours 1, 3

  2. Inadequate NPH dosing: The systematic review emphasizes that "adequate NPH dosing has not been identified because insulin regimens assessed thus far have been suboptimal" 1. Don't be timid with dose increases.

  3. Premature dose reduction: When dexamethasone is eventually discontinued, insulin requirements can decline rapidly 3. Reduce NPH by 50% on the day after last dexamethasone dose, then titrate down by 20% daily based on glucose response.

  4. Ignoring meal timing: NPH peaks 4-8 hours post-injection. The 10 am dose peaks during afternoon/evening meals; the 8 pm dose peaks overnight. Ensure consistent meal timing.

Alternative Consideration

If hyperglycemia persists despite these adjustments, consider transitioning to basal-bolus insulin (BBI) regimen with 40% basal (glargine or detemir) and 60% prandial (rapid-acting analog) 1. The 2022 systematic review notes "BBI with NPH showed the greatest likelihood of effectiveness" but acknowledges that standalone BBI at 0.5-0.6 units/kg is also effective 1.

For this 120 kg patient, BBI would be:

  • Total daily dose: 60-72 units (0.5-0.6 units/kg)
  • Basal: 24-29 units daily
  • Prandial: 12-14 units per meal

However, continue with twice-daily NPH initially as recommended specifically for dexamethasone-induced hyperglycemia 1, reserving BBI transition for refractory cases.

References

1
Guideline

glucocorticoid-induced hyperglycemia including dexamethasone-associated hyperglycemia in covid-19 infection: a systematic review.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

3
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Related Questions

What is the maximum dose per injection of NPH insulin (neutral protamine Hagedorn) for a 71‑kg patient who administers it twice daily (morning and evening)?
For a 27‑year‑old female on dexamethasone 20 mg daily who is currently taking 52 U of NPH insulin (Neutral Protamine Hagedorn) at 08:00 and using an insulin‑to‑carbohydrate ratio (ICR) of 3 g per unit (insulin sensitivity factor 15 mg/dL), with blood glucose readings of 213 mg/dL at 08:00, 269 mg/dL at 13:00, 96 mg/dL at 15:00, 278 mg/dL at 22:00, and 285 mg/dL at 01:00, what should the 08:00 NPH dose be, what should the ICR be, and what dose of NPH insulin should be added at 20:00?
Patient with HbA1c of 7.3% using neutral protamine Hagedorn (NPH) insulin 13 units at bedtime and 20 units before breakfast, how should the insulin regimen be adjusted?
What 8 am dose of NPH (neutral protamine Hagedorn) insulin should be given to a 67‑year‑old male with type 2 diabetes, weight 142 kg, serum creatinine 2.10 mg/dL (GFR 29 mL/min), one week post‑liver transplant, on continuous total feed (201 g carbohydrate per 24 h) with an insulin‑to‑carbohydrate ratio of 1 unit per 10 g carbohydrate but minimal oral intake, who received 20 units of NPH at 8 pm and has been on an insulin drip with rates of 2,2,2,3,3,4,4,3,3,3 units/h since 8 pm and wishes to discontinue the drip?
What rapid‑acting insulin dose should be given now for a patient who received NPH (neutral protamine Hagedorn) 10 units four hours ago, has high‑dose prednisone/methylprednisolone therapy, an eGFR of 33 mL/min, and a current capillary glucose likely above 200 mg/dL?
How should a 50-year-old man with bilateral eye irritation and burning sensation for 15 days after hair dye application, with swelling of the lower eyelids but normal conjunctiva and cornea, be managed?
Is bright red blood on the surface of stool typically caused by hemorrhoids, and what is the recommended initial management?
How should I manage a patient with a SureSwab that detects Candida species but does not differentiate the species?
Can Depakote (valproic acid) cause confusion?
What are the diagnosis, symptoms, and treatment for trichomoniasis?
What are the indications, recommended dosing, and duration for oral corticosteroids in COPD exacerbations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.